|
Volume
7 Number 5
May 2019
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer
Reviews
>
Volume
7, Year 2019 >
Number 5, May
|
|
|
CONTENTS
|
▼
|
|
CLASSIFICATION
DIAGNOSIS
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
FOLLOW-UP,
QUALITY OF LIFE
INTEGRATIVE
MEDICINE
OVERALL
MANAGEMENT
PROGNOSIS
TREATMENT
|
|
|
CLASSIFICATION
|
▲
|
.
|
Paner GP, Gandhi J, Choy B, Amin MB.
Essential Updates in
Grading, Morphotyping, Reporting, and Staging of Prostate
Carcinoma for General Surgical Pathologists.
Arch Pathol
Lab Med. 2019 Mar 13. doi: 10.5858/arpa.2018-0334-RA. [Epub ahead
of print]
Source
.
Similar
articles
|
|
|
DIAGNOSIS
|
▲
|
.
|
Barakzai MA.
Prostatic Adenocarcinoma: A Grading from
Gleason to the New Grade-Group System: A Historical and Critical
Review
Asian Pac J Cancer Prev. 2019 Mar
26;20(3):661-666.
Source
.
Similar
articles
|
|
|
.
|
Ekmekcioglu O, Busstra M, Klass ND, Verzijlbergen F.
Bridging
the imaging gap: PSMA PET/CT has a high impact on treatment
planning in prostate cancer patients with biochemical recurrence -
a narrative review of literature.
J Nucl Med. 2019 Mar
8. pii: jnumed.118.222885. doi: 10.2967/jnumed.118.222885. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Emberton M.
To see or not to see - what renders prostate
cancer visible?
Nat Rev Urol. 2019 Mar 13. doi:
10.1038/s41585-019-0167-5. [Epub ahead of print]
Source
.
Similar
articles
Comment
on: Houlahan KE et al., Molecular Hallmarks of Multiparametric
Magnetic Resonance Imaging Visibility in Prostate Cancer.
Eur
Urol. 2019 Jan 24. pii: S0302-2838(18)31044-3. doi:
10.1016/j.eururo.2018.12.036. [Epub ahead of print].
Source
.
Similar
articles
|
|
|
.
|
Galetti TP.
Is digital rectal examination still useful in
prostate cancer diagnosis? YES!
Urologia. 2019
Feb;86(1):34. doi: 10.1177/0391560319834463.
Source
.
Similar
articles
|
|
|
.
|
Lebastchi AH, Pinto PA.
The role of multiparametric MRI
in biopsy-naive prostate cancer.
Nat Rev Urol. 2019 Mar
26. doi: 10.1038/s41585-019-0173-7. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Miles B, Ittmann M, Wheeler T, Sayeeduddin M, Cubilla A, Rowley D,
Bu P, Ding Y, Gao Y, Lee M, Ayala GE.
Moving Beyond
Gleason Scoring.
Arch Pathol Lab Med. 2019 Mar 13. doi:
10.5858/arpa.2018-0242-RA. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Sackett J, Choyke PL, Turkbey B.
Prostate Imaging
Reporting and Data System Version 2 for MRI of Prostate Cancer:
Can We Do Better?
AJR Am J Roentgenol. 2019 Mar 19:1-9.
doi: 10.2214/AJR.19.21178. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Tan N, Bavadian N, Calais J, Oyoyo U, Kim J, Turkbey IB, Mena E,
Davenport MS.
Imaging of PSMA-targeted Radiotracers for
the Detection of Prostate Cancer Biochemical Recurrence After
Definitive Therapy: A Systematic Review and Meta-analysis.
J
Urol. 2019 Feb 25:101097JU0000000000000198. doi:
10.1097/JU.0000000000000198. [Epub ahead of print]
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Totaro A.
Is digital rectal examination still useful in
prostate cancer diagnosis? NO!
Urologia. 2019
Feb;86(1):32-33. doi: 10.1177/0391560319834462.
Source
.
Similar
articles
|
|
|
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
|
▲
|
.
|
Kaiser A, Haskins C, Siddiqui MM, Hussain A, D'Adamo C.
The
evolving role of diet in prostate cancer risk and progression.
Curr Opin Oncol. 2019 Mar 15. doi:
10.1097/CCO.0000000000000519. [Epub ahead of print]
Source
|
Abstract
|
Similar
articles
|
|
|
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
|
▲
|
.
|
Sowder ME, Johnson RW.
Bone as a Preferential Site for
Metastasis.
JBMR Plus. 2019 Jan 15;3(3):e10126. doi:
10.1002/jbm4.10126. eCollection 2019 Mar.
Source
.
Similar
articles
|
|
|
.
|
Özdemir BC, Dotto GP.
Sex Hormones and Anticancer
Immunity.
Clin Cancer Res. 2019 Mar 19. doi:
10.1158/1078-0432.CCR-19-0137. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Catton CN, Shultz DB.
Should we expand the carbon ion
footprint of prostate cancer?
Lancet Oncol. 2019 Mar 15.
pii: S1470-2045(19)30094-4. doi: 10.1016/S1470-2045(19)30094-4.
[Epub ahead of print]
Source
.
Similar
articles
Comment
on: Mohamad O et al., Risk of subsequent primary cancers after
carbon ion radiotherapy, photon radiotherapy, or surgery for
localised prostate cancer: a propensity score-weighted,
retrospective, cohort study. Lancet Oncol. 2019 Mar 15. doi:
10.1016/S1470-2045(18)30931-8. [Epub ahead of print].
Source
.
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
.
|
Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.
Mortality
associated with statins in men with advanced prostate cancer
treated with androgen deprivation therapy.
Eur J Cancer.
2019 Feb 28. pii: S0959-8049(19)30047-4. doi:
10.1016/j.ejca.2018.11.032. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
OVERALL
MANAGEMENT
|
▲
|
.
|
Calzone KA et al., PDQ Cancer Genetics Editorial Board.
Genetics
of Prostate Cancer (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Mar 22.
Source
.
Similar
articles
|
|
|
.
|
Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo
SS, Moghanaki D, Loblaw A, Siva S.
Trends in Management
of Oligometastatic Hormone-Sensitive Prostate Cancer.
Curr
Oncol Rep. 2019 Mar 27;21(5):43. doi: 10.1007/s11912-019-0791-5.
Source
.
Similar
articles
|
|
|
.
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Mar 22.
Source
.
Similar
articles
|
|
|
.
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Prevention (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Mar 1.
Source
.
Similar
articles
|
|
|
.
|
Muggia FM, et al., PDQ Adult
Treatment Editorial Board.
Prostate Cancer
Treatment (PDQ®): Patient Version.
PDQ Cancer
Information Summaries [Internet]. Bethesda (MD): National Cancer
Institute (US); 2019 Feb 28.
Source
.
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
.
|
Lu TC, Collins L, Cohen P, Jay A, Campbell JM, O'Callaghan M.
Prognostic Differences in ISUP Grade Group 4: a
Systematic Review and Meta-Analysis.
Pathol Oncol Res.
2019 Mar 14. doi: 10.1007/s12253-019-00632-1. [Epub ahead of
print]
Source
.
Similar
articles
|
|
|
TREATMENT
|
▲
|
.
|
Livi L, Detti B, Francolini G, Terziani F, Triggiani L,
D'Angelillo RM, Ingrosso G.
Combining abiraterone and
radiotherapy in metastatic castration-resistant prostate cancer: a
review of current evidence.
Tumori. 2019 Mar
25:300891619839282. doi: 10.1177/0300891619839282. [Epub ahead of
print]
Source
.
Similar
articles
|
|
|
.
|
Pellizzon ACA.
Are we ready to use hypofractionated
instead of conventional radiotherapy for prostate cancer? Not yet.
Int Braz J Urol. 2019 Jan-Feb;45(1):5-9. doi:
10.1590/S1677-5538.IBJU.2018.0734. Epub 2019 Jan 23.
Source
.
Similar
articles
|
|
|
.
|
Roviello G, Generali D.
New-Generation Hormone Therapies
in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who,
When.
Clin Genitourin Cancer. 2019 Feb 6. pii:
S1558-7673(18)30797-3. doi: 10.1016/j.clgc.2019.01.020. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Sternberg CN.
Enzalutamide, an oral androgen receptor
inhibitor for treatment of castration-resistant prostate cancer.
Future Oncol. 2019 Mar 8. doi: 10.2217/fon-2018-0940.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
bottom
|
▲
|
|
|
